The UNVC LinkedIn announcement is a collection of regulatory buzzwords that legally conflict with one another. Relying on it for investment decisions would be incredibly risky, as the public record does not backup the graphic's claims.
Can't have it both ways... The announcement claims the product will transition into "e-prescribing networks" (meaning it operates as a prescription drug) and that it "bypasses organ toxicities." Yet, the footnote uses a standard DSHEA disclaimer stating it is "not intended to diagnose, treat, cure, or prevent any disease"—a statement legally required for dietary supplements, not prescription drugs.
Reality: Under FDA law, a product cannot be a prescription drug while simultaneously claiming it doesn't treat any disease.
The post promises a rollout in "the coming weeks," but the product lacks an active National Drug Code (NDC) number. Without this formal FDA registration, it is logistically and legally impossible to onboard a product into healthcare e-prescribing systems.
The company's official OTC Markets profile explicitly states they do not use LinkedIn for investor communications. All other means of Investor Communication: X (Twitter): N/A | Discord: N/A | LinkedIn: N/A | Facebook: N/A......This triggers intense regulatory scrutiny under SEC Rule 10b-5,
Disclaimer: This post is for informational and educational purposes only and does not constitute financial, legal, or investment advice.
PL
Can't have it both ways... The announcement claims the product will transition into "e-prescribing networks" (meaning it operates as a prescription drug) and that it "bypasses organ toxicities." Yet, the footnote uses a standard DSHEA disclaimer stating it is "not intended to diagnose, treat, cure, or prevent any disease"—a statement legally required for dietary supplements, not prescription drugs.
Reality: Under FDA law, a product cannot be a prescription drug while simultaneously claiming it doesn't treat any disease.
The post promises a rollout in "the coming weeks," but the product lacks an active National Drug Code (NDC) number. Without this formal FDA registration, it is logistically and legally impossible to onboard a product into healthcare e-prescribing systems.
The company's official OTC Markets profile explicitly states they do not use LinkedIn for investor communications. All other means of Investor Communication: X (Twitter): N/A | Discord: N/A | LinkedIn: N/A | Facebook: N/A......This triggers intense regulatory scrutiny under SEC Rule 10b-5,
Disclaimer: This post is for informational and educational purposes only and does not constitute financial, legal, or investment advice.
PL
